Through comparing the photocatalytic performance of microscale ZnO, nano ZnO, and Degussa P25 titania (P25), it was found that the microscale ZnO exhibited 2.6-35.7 times higher photocatalytic activity for the photodegradation of various dye pollutants than P25 under both UV-visible and visible irradiation and showed much better photostability than the nano ZnO. The photocatalysts were characterized with XRD, Raman, BET, DRUV-vis, adsorption of dye, photoelectrochemical measurement, and PL. The much higher photocataltyic activity of the microscale ZnO than P25 under UV-visible irradiation is attributed to the higher efficiency of generation, mobility, and separation of photoinduced electrons and holes. The much higher visible photocataltyic activity of the microscale ZnO than P25 is due to the higher photosensitization efficiency of electron transfer from an excited dye to the conduction band of the microscale ZnO than that of P25. The much better photostability of the microscale ZnO than the nano ZnO is due to its better crystallinity and lower defects. The photostability of the microscale ZnO is greatly improved by the surface modification of ZnO with a small amount of TiO(2). On the basis of the excellent photocatalytic performance of the microscale ZnO and TiO(2)-modified ZnO, a novel device of coupling photodegradation with light-to-electricity conversion was developed, which is a promising candidate for the photocatalytic removal of dye pollutants and a renewable energy source.

The maternal high-E2 environment in the first trimester is correlated with increased risks of LBW and SGA. Evaluation of serum E2 before ET should be adopted to reduce the possibility of high E2 exposure to gamete/embryo.

Although previous studies have shown that the tumor necrosis factor-alpha (TNF) gene is expressed in pregnancy decidua, it has not been determined whether this gene is transcribed or translated in the endometrium prior to implantation. To address this question and to identify cells expressing the TNF gene, samples of normal cycling human endometria were tested for TNF mRNA by in situ hybridization using a biotinylated antisense RNA probe, and the corresponding protein was localized in the same tissues by immunocytochemistry with a monoclonal antibody to TNF. Both TNF message and protein were identified in the endometrium throughout the menstrual cycle, and the same types of cells that contained transcripts also contained protein. As judged by the intensities of the hybridization signals, TNF mRNA increased during the proliferative phases, declined in the early secretory phase, and again rose during mid-to-late secretory phases, suggesting positive associations with levels of female sex hormones that show similar cyclic fluctuations. At the initiation of the cycle, transcripts were primarily localized to glandular epithelial cells whereas by the midproliferative phase, message was also present in stromal cells. Hybridization signals were consistently more intense in functionalis-region than in basalis-region stromal cells, and were frequently stronger in basalis-region glandular epithelia than in functionalis-region glands. These observations document that the TNF gene is expressed in normal cycling endometria, suggest that ovarian hormones may regulate TNF gene transcription, and identify differences in specific endometrial compartments. The findings are also consistent with the postulate that TNF is a local mediator of cellular communications in the human endometrium.

No abstract

No abstract